A review on plant-derived natural products and their analogs with anti-tumor activity
2008

Review of Plant-Derived Natural Products with Anti-Tumor Activity

publication Evidence: moderate

Author Information

Author(s): Dholwani K.K., Saluja A.K., Gupta A.R.

Primary Institution: A.R College of Pharmacy affiliated to Sardar Patel University

Hypothesis

Can plant-derived natural products and their analogs be developed into effective anti-tumor agents?

Conclusion

The study highlights the potential of plant-derived compounds, particularly GL331, as promising candidates for anticancer drug development.

Supporting Evidence

  • GL331 is currently in anticancer clinical trials.
  • Nine plant-derived compounds have been approved for use as anticancer drugs in the US since 1961.
  • Preclinical screening identifies promising drug development targets.

Takeaway

Scientists are looking at plants to find new medicines that can help fight cancer. One promising candidate is GL331, which is being tested in people.

Methodology

The study involved bioactivity-directed isolation, characterization, and modification of plant-derived compounds, followed by preclinical screening in human cell lines and xenograft models.

Limitations

The review does not provide specific quantitative data on the efficacy of the compounds discussed.

Digital Object Identifier (DOI)

10.4103/0253-7613.41038

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication